These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 4150601)

  • 1. Letter: Beta-blocking agents and platelet aggregation.
    Rubegni M; Provvedi D; Bellini PG
    JAMA; 1974 Apr; 228(4):462. PubMed ID: 4150601
    [No Abstract]   [Full Text] [Related]  

  • 2. Beta-blocking drugs and human platelet aggregation in vitro.
    Gibelli A; Montanari C; Bellani D; Mandelli V; Sacchetti G
    Experientia; 1973 Feb; 29(2):186-7. PubMed ID: 4144249
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of bupranolol, a new beta-blocker, on platelet functions of rabbit and human in vitro.
    Umetsu T; Sanai K; Kato T
    Thromb Haemost; 1976 Nov; 36(2):376-87. PubMed ID: 12593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study of the action of beta adrenergic blocking agents on platelet adhesiveness and fibrinolysis in atherosclerosis].
    Nicolaescu V; Ionăşescu R; Pompilian P; Teodorescu P
    Med Interna (Bucur); 1970 Dec; 22(12):1497-503. PubMed ID: 4396020
    [No Abstract]   [Full Text] [Related]  

  • 5. [Inhibition of platelet aggregation and its clinical use (author's transl)].
    Cepelák V
    Cas Lek Cesk; 1974 Jan; 113(2):51-5. PubMed ID: 4154807
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of beta-blocking agents on platelet aggregation].
    Zawilska K; Komarnicki M; Mańka B
    Pol Arch Med Wewn; 1975 Aug; 54(2):203-8. PubMed ID: 240155
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of alpha and beta receptor stimulating and blocking agents on experimental disseminated intravascular coagulation.
    Moriau M; Noel H; Masure R
    Thromb Diath Haemorrh; 1974 Sep; 32(1):157-70. PubMed ID: 4156098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects "in vitro" of some cardiovascular drugs and other agents on human platelet aggregation.
    Sacchetti G; Bellani D; Montanari C; Gibelli A
    Thromb Diath Haemorrh; 1973 Feb; 29(1):190-5. PubMed ID: 4145347
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of alpha- and beta-receptor blocking agents on collagen-induced platelet release reaction. (A comparison with ADP-induced release).
    Kubisz P; Suranova J
    Thromb Diath Haemorrh; 1972 Apr; 27(2):278-91. PubMed ID: 4403161
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of some beta-blocking drugs on plasma renin activity, platelet adhesiveness and dilute blood clot lysis time in patients with essential arterial hypertension.
    Vlaicu R; Uza G; Mărcuş C; Voinescu I
    Med Interne; 1980; 18(3):247-51. PubMed ID: 6106281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of nitrates and beta-blockers on platelet aggregation in patients with coronary heart disease].
    Wlazłowski R; Kruszyński G; Goch JH
    Pol Merkur Lekarski; 2000 Feb; 8(44):77-9. PubMed ID: 10808734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the effects of carvedilol, propranolol, and verapamil on in vitro platelet function in healthy volunteers.
    Gasser JA; Betterridge DJ
    J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S29-34. PubMed ID: 1721976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies on platelet aggregation inhibitory agents (author's transl)].
    Ukita M; Kitahara T; Hosokawa T; Kato M; Suzuki Y; Otomo H
    Nihon Ketsueki Gakkai Zasshi; 1974 Apr; 37(2):161-5. PubMed ID: 4369675
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of phentolamine and propranolol an alpha and beta receptor blocking agent, on epinephrine and ADP induced platelet factor 3, platelet acid phosphatase availability and platelet factor 4 release.
    Kubisz P
    Acta Univ Carol Med Monogr; 1972; 53():79-90. PubMed ID: 4670758
    [No Abstract]   [Full Text] [Related]  

  • 15. [Mechanism of thrombocyte aggregation inhibition caused by sulfonylurea compounds. 3. Significance of prostaglandins and cAMP for aggregation inhibiting effect and other effects of sulfonylurea compounds].
    Scholz VC; Hoder A; Losert W
    Arzneimittelforschung; 1975 Mar; 25(3):347-61. PubMed ID: 239727
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of alpha- and beta-adrenergic antagonist on epinephrine-induced aggregation and intracellular free calcium concentration in human platelets.
    Kimura Y; Okuda H
    Biochem Biophys Res Commun; 1994 Jul; 202(2):1069-75. PubMed ID: 7914077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet adhesiveness, plasma fibrinogen and fibrinolytic activity in angina pectoris before and after propranolol therapy.
    Mehrotra TN; Mital HS; Singh VS; Kumar A; Sinha AK; Raka MS
    J Assoc Physicians India; 1983 Oct; 31(10):641-3. PubMed ID: 6671933
    [No Abstract]   [Full Text] [Related]  

  • 18. A comparative study of the effects of adrenoceptor antagonists on platelet aggregation and thromboxane generation.
    Greer IA; Walker JJ; McLaren M; Calder AA; Forbes CD
    Thromb Haemost; 1985 Aug; 54(2):480-4. PubMed ID: 2867620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propranolol modifies platelet serotonergic mechanisms in rats.
    Zółtowski R; Pawlak R; Matys T; Pietraszek M; Buczko W
    J Physiol Pharmacol; 2002 Jun; 53(2):265-74. PubMed ID: 12120901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between the potency of seven potential beta-adrenoceptor blocking drugs and propranolol to decrease heart rate in reserpinized rats and to perturb liposomes prepared from platelet lipids.
    Ondriasova E; Stasko A; Racanská E; Svec P; Ondrias K
    Pharmazie; 1991 Dec; 46(12):889-90. PubMed ID: 1687834
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.